Skip to main content
Log in

Policies to address disparities in clinical trials: The EDICT project

  • Published:
Journal of Cancer Education Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Baquet CR, Commiskey P, Mullins CD, Mishra SI. Recruitment and participation in clinical trials: sociodemographic, rural/urban, and health care access predictors.Cancer Detect Prev. 2006; 30:24–33.

    Article  PubMed  Google Scholar 

  2. Corbie-Smith G, Miller WC, Ransohoff, DF. Interpretations of ‘appropriate’ minority inclusion in clinical research.Am J Med. 2004; 116:249–52.

    Article  PubMed  Google Scholar 

  3. Swanson GM, Bailar JC. Selection and description of cancer clinical trials participants — science or happenstance?Cancer. 2002; 95:950–959.

    Article  PubMed  Google Scholar 

  4. Janson SL, Alioto ME, Boushey HA. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial.Controlled Clinical Trials. 2001;6:S236-S243.

    Article  Google Scholar 

  5. Brandon, DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care?J Natl Med Assoc. 2005; 97:951–956.

    PubMed  Google Scholar 

  6. Seto, B. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research.Am J Med Sci. 2001;322:246–50.

    Article  Google Scholar 

  7. Comis RL, Aldige CR, Stovall EL, Krebs LU, Risher PJ, Taylor HJ. Public attitudes toward participation in cancer clinical trials.J Clin Oncol. 2003:5:830–835.

    Article  Google Scholar 

  8. National Cancer Institute. Cancer Clinical Trials: The Basic Workbook. Available from: http://www.cancer.gov/clinicaltrials/resources/basicworkbook. Accessed November 18, 2009.

  9. Nguyen TT, Somkin CP, Ma Y. Participation of Asian-American women in cancer chemoprevention research: physician perspectives.Cancer. 2005; 104:3006–14.

    Article  PubMed  Google Scholar 

  10. Killien M, Bigby JA, Champion V, et al. Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women’s Health.J Womens Health Gend Based Med. 2000; 9:1061–70.

    Article  CAS  PubMed  Google Scholar 

  11. Ross S, Grant A, Counsell C, et al. Barriers to participation in randomized controlled trials: a systematic review.J Clin Epidemiol. 1999; 52:1143–56.

    Article  CAS  PubMed  Google Scholar 

  12. Goldman DP, Berry SH, McCabe MS, et al. Incremental treatment costs in National Cancer Institute-sponsored clinical trials.JAMA. 2003;289:2970–2977.

    Article  PubMed  Google Scholar 

  13. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers.J Clin Oncol. 2004; 22:730–734.

    Article  PubMed  Google Scholar 

  14. Gross CP, Herrin J, Wong N, Krumholz HM. Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics.J Clin Oncol. 2005; 23:4755–4763.

    Article  PubMed  Google Scholar 

  15. Crosson, K, Eisner E, Brown C, Ter Maat J. Primary care physicians’ attitudes, knowledge, and practices related to cancer clinical trials.J Cancer Educ. 2001;16:188–192.

    CAS  PubMed  Google Scholar 

  16. Howerton MW, Gibbons MC, Baffi CR, et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials.Cancer. 2007;109: 465–476.

    Article  PubMed  Google Scholar 

  17. Hudson SV, Momperousse D, Leventhal H. Physician perspectives on cancer clinical trials and barriers to minority recruitment.Cancer Control. 2005; 12:93–6.

    PubMed  Google Scholar 

  18. Getz KA. Racial disparities among clinical research investigators.Am J Ther. 2008;15: 319.

    Google Scholar 

  19. Ford JG, Howerton MW, Bolen S, et al. Knowledge and Access to Information on Recruitment of Underrepresented Populations to Cancer Clinical Trials. Evidence Report: Technology Assessment No.122, AHRQ Publication No. 05-E019-2. Rockville, MD. Agency for Healthcare Research and Quality. June 2005.

    Google Scholar 

  20. Geller EG, Goldstein M, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.Journal of Women’s Health. 2006;15:1123–1131.

    Article  PubMed  Google Scholar 

  21. Fouad MN, Partridge E, Green BL, Wynn T, Nagy S, Churchill S. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community.Ann Epidemiol. 2000; 10: S35–40.

    Article  CAS  PubMed  Google Scholar 

  22. Increasing minority participation in clinical research: a white paper from the Endocrine Society. December 2007. Available from: http://www.endo-society.org/advocacy/health_disparities/index.cfm# Accessed November, 18, 2009.

  23. Noah, BA. The participation of underrepresented populations in clinical research.J Law Med Med. 2003:29:221–224.

    Google Scholar 

  24. Rdesinski RE, Melnick AL, Creach ED, Cozzens J, Carney PA. The cost of recruitment and retention of women from community-based programs into a randomized controlled contraceptive study.J Health Care Poor Underserved. 2008;19:639–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cynthia A. Spiker MPH.

Additional information

The EDICT project is funded by an unrestricted educational grant from Genentech, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spiker, C.A., Weinberg, A.D. Policies to address disparities in clinical trials: The EDICT project. J Canc Educ 24 (Suppl 2), S39–S49 (2009). https://doi.org/10.1007/BF03182311

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03182311

Keywords

Navigation